References
- Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol 1994, 130, 359–362.
- Döring HF, Ilgner M. [Therapy of rosacea with bifonazole cream–practical experiences over a 2-year period]. Z Hautkr 1986, 61, 490–494.
- Utaş S, Ünver Ü. Treatment of rosacea with ketoconazole. J Eur Acad Dermatol Venerol 1997, 8, 69–70.
- Nielsen PG. Treatment of rosacea with 1% metronidazole cream. A double-blind study. Br J Dermatol 1983, 108, 327–332.
- Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol 1986, 114, 231–234.
- Grove DI, Mahmound AA, Warren KS. Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol 1977, 54, 422–427.
- Choczaj-Kukula A, Kwasniewska J. [Current possibilities of using antimycotic drugs in the treatment of various skin disorders]. Wiad Parazytol 2004, 50, 125–133.
- Camera E, Cannistraci C, Briganti S, Colombo D, Picardo M. Scavenging effects of terbinafine on free radicals in vitro. Br J Dermatol 1999, 140, 640–644.
- Sander CS, Hipler UC, Wollina U, Elsner P. Inhibitory effect of terbinafine on reactive oxygen species (ROS) generation by Candida albicans. Mycoses 2002, 45, 152–155.
- Rosen T, Schell BJ, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Dermatol 1997, 36, 788–792.
- Rashid A, Williams TG. Oral Terbinafine in the Treatment of Rosacea. Poster at Annual Meeting of the AAD 2001.
- Jiflu M, Neamtu S. Terbinafine, modality of treatment in rosacea. J Eur Acad Dermatol Venereol 2003, 17, 165–426.